News And Article

Category: Blog

Blog
Acute Lymphoblastic Leukemia

Previous blog Next blog 9 February 2026 Acute lymphoblastic leukemia represents both heartbreak and hope. Whilst it is the most common cancer in children, modern

Blog
Acute Myeloid Leukemia

Previous blog Next blog 9 February 2026 Acute myeloid leukemia announces itself dramatically. Unlike chronic leukemias that develop slowly over months or years, this aggressive

Blog
Chronic Lymphocytic Leukemia

Previous blog Next blog 9 February 2026 Chronic lymphocytic leukemia occupies a unique place among blood cancers. Many patients live with the disease for years,

Blog
Chronic Myeloid Leukemia

Previous blog Next blog 9 February 2026 Around twenty years ago, chronic myeloid leukemia was a devastating diagnosis. Patients faced a median survival of just

Blog
Understanding Anaemia

Previous blog Next blog 9 February 2026 Anaemia is perhaps the most common blood disorder worldwide, affecting nearly one in three Indians. Despite its prevalence,

SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct head and neck cancer case study using TCR-p53 therapy in inoperable squamous cell carcinoma
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male